Umbilical cord blood transplantation for acute myeloid leukemia

Current Opinion in Hematology

Volumn 16, Issue 2, 2009, Pages 124-128

  Advani, Anjali S ^a,c   Laughlin, Mary J ^b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute myeloid leukemia; Prognosis; Umbilical cord blood transplant

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IMMUNE SYSTEM; INFECTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE;

EID: 62249106608     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3283257a60     Document Type: Review

References (27)

1. Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplant. Br J Haematol 2007; 137:20-35.
2. Brunstein CG, Wagner JE. Cord blood transplantation for adults. Vox Sang 2006; 91:195-205.
3. Brunstein CG, Baker KS, Wagner JE. Umbilical cord blood transplantation for myeloid malignancies. Curr Opin Hematol 2007; 14:162-169.
4. Liao C, Wu JY, Xu ZP, et al. Indiscernible benefit of high-resolution HLA typing in improving long-term clinical outcome of unrelated umbilical cord blood transplant. Bone Marrow Transplant 2007; 40:201-208. A retrospective analysis demonstrating that high-resolution typing does not improve outcomes in unrelated UCBT.
5. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351:2265-2275.
6. Rocha V, Labopin M, Sanz G, et al. Transplants of umblical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004;351:2276-2285.
7. Takahashi S, Ooi J, Tomonari A, et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007; 109:1322-1330. A single-institution study demonstrating comparable outcomes in patients with hematologic malignancies (primarily AML) receiving cord blood transplants from URDs versus those receiving transplants with bone marrow or peripheral blood from related donors.
8. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004; 103:489-491.
9. 1 and demonstrated comparable outcomes in the two groups; thus, demonstrating the safety and efficacy of this approach for patients without a MRD.
10. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106:2912-2919.
11. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001; 344:1870-1871.
12. - NK cells in the peripheral blood of cord blood transplant recipients with AML, thereby suggesting that NK cells may play an important role in the GVL effect after UCBT.
13. Arora M, Nagaraj S, Wagner JE, et al. Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation: higher response rates in recipients of unrelated donor (URD) umbilical cord blood (UCB). Biol Blood and Marrow Transplant 2007; 13:1145-1152. A large retrospective study demonstrating improved outcomes to GVHD treatment in UCB recipients versus URD recipients.
14. Komanduri KV, St John LS, de Lima M, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T cell skewing. Blood 2007; 110:4543-4551. The first robust prospective study evaluating changes in the immune system, including impaired thymopoiesis and late memory T-cell skewing, after UCBT.
15. Hofmeister CC, Zhang J, Knight KL, et al. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 2007; 39:11-23.
16. Rieber AG, Parmar S, Robinson SN, et al. Optimization of expansion of cord blood T cells with anti-CD3/anti-CD28 coated beads, Biol Blood Marrow Transplant 2006; 12 (2 Suppl 1):81-82.
17. Park KD, Marti L, Kurtzberg J, et al. In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes. Blood 2006; 108:1770-1773.
18. Haspel RL, Ballen KK. Double cord blood transplants. Filling a Niche? Stem Cell Rev 2006; 2:81-86.
19. Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32:397-407.
20. + cell doses. Biol of Blood and Marrow Transplant 2007; 13:822-830. A large study demonstrating the importance of cell dose in UCBT on clinical outcomes.
21. Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105:1343-1347.
22. Verneris MR, Brunstein C, DeFor TE, et al. Risk of relapse (REL) after umbilical cord blood transplantation (UCBT) in patients with acute leukemia: marked reduction in recipients of two units [abstract]. Blood 2005; 106:93a.
23. Ballen KK, Spitzer TR, Yeap B, et al. Excellent disease-free survival after double cord blood transplantation using a reduced intensity chemotherapy only conditioning regimen in a diverse adult population [abstract #2048]. ASH Annu Meeting Abstr 2005; 106:.
24. Lister J, Gryn JF, McQueen KL, et al. Multiple unit HLA-unmatched sexmismatched umbilical cord blood transplantation for advanced hematological malignancy. Stem Cells Dev 2007; 16:177-186.
25. Rosenzwajg M, Giarratana MC, Gluckman JC, et al. Incidence of ex vivo expansion on the capacity of cord blood graft to generate immune cells: rational for co-infusion of expanded and non expanded fractions? [Abstract #407], Blood 2004; 104:.
26. Shpall EJ, de Lima M, McMannis JD, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2005; 11:932.
27. Robinson SN, Ng J, Niu T, et al. Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant 2006; 37:359-366.